prnewswire.comStryker receives FDA clearance for OptaBlate BVN Basivertebral Nerve Ablation System3 months ago
businesswire.comBuenaventura Announces Fourth Quarter 2024 Results for Production and Volume Sold per Metal6 months ago
businesswire.comBuenaventura Announces Fourth Quarter 2024 Results for Production and Volume Sold per Metal6 months ago
businesswire.comBuenaventura Announces Third Quarter 2024 Results for Production and Volume Sold per Metal10 months ago
CashuCompania de Minas Buenaventura S.A. Highlights Stryker's FDA-Cleared OptaBlate BVN for Pain Management2 months ago